open access

Vol 71, No 2 (2021)
Invited editorial
Published online: 2021-04-06
Get Citation

Rectal NET treatment – current approach

Maciej Matyja, Michał Pędziwiatr
DOI: 10.5603/NJO.2021.0024
·
Nowotwory. Journal of Oncology 2021;71(2):117-118.

open access

Vol 71, No 2 (2021)
Invited editorial
Published online: 2021-04-06

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Rectal NET treatment – current approach

Journal

Nowotwory. Journal of Oncology

Issue

Vol 71, No 2 (2021)

Article type

Invited editorial

Pages

117-118

Published online

2021-04-06

DOI

10.5603/NJO.2021.0024

Bibliographic record

Nowotwory. Journal of Oncology 2021;71(2):117-118.

Authors

Maciej Matyja
Michał Pędziwiatr

References (11)
  1. Dasari A, Shen C, Halperin D, et al. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States. JAMA Oncol. 2017; 3(10): 1335–1342.
  2. Ito T, Igarashi H, Nakamura K, et al. Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis. J Gastroenterol. 2015; 50(1): 58–64.
  3. Bertani E, Ravizza D, Milione M, et al. Neuroendocrine neoplasms of rectum: A management update. Cancer Treat Rev. 2018; 66: 45–55.
  4. Radulova-Mauersberger O, Stelzner S, Witzigmannn H. [Rectal neuroendocrine tumors: surgical therapy]. Chirurg. 2016; 87(4): 292–297.
  5. Boškoski I, Volkanovska A, Tringali A, et al. Endoscopic resection for gastrointestinal neuroendocrine tumors. Expert Rev Gastroenterol Hepatol. 2013; 7(6): 559–569.
  6. Konishi T, Watanabe T, Kishimoto J, et al. Japanese Society for Cancer of the Colon and Rectum. Prognosis and risk factors of metastasis in colorectal carcinoids: results of a nationwide registry over 15 years. Gut. 2007; 56(6): 863–868.
  7. Shields CJ, Tiret E, Winter DC, et al. International Rectal Carcinoid Study Group. Carcinoid tumors of the rectum: a multi-institutional international collaboration. Ann Surg. 2010; 252(5): 750–755.
  8. Tierney JF, Chivukula SV, Wang X, et al. Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors. Surgery. 2019; 165(3): 644–651.
  9. Zubaryev M, Kim HS, Min BS. Local excision vs. radical surgery in treating rectal nets considering the biology of neuroendocrine tumors (NETs). Nowotwory. Journal of Oncology. 2021; 71(1): 9–16.
  10. Ziv Y, Zbar A, Bar-Shavit Y, et al. Low anterior resection syndrome (LARS): cause and effect and reconstructive considerations. Tech Coloproctol. 2013; 17(2): 151–162.
  11. Eto K, Yoshida N, Iwagami S, et al. Surgical treatment for gastrointestinal neuroendocrine tumors. Ann Gastroenterol Surg. 2020; 4(6): 652–659.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media sp. z o.o. VM Group sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl